S.C. Ropharma S.A. (BVB:RPH)
Romania · Delayed Price · Currency is RON 0.2020
0.00 (0.00%)
At close: Jun 30, 2026
S.C. Ropharma Income Statement
Financials in millions RON. Fiscal year is January - December.
Millions RON. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,447 | 1,389 | 1,191 | 1,006 | 912.74 | 776.69 |
Other Revenue | 147.79 | 149.25 | 132.11 | 113.83 | 89.23 | 111.47 |
| 1,595 | 1,538 | 1,323 | 1,120 | 1,002 | 888.16 | |
Revenue Growth (YoY) | 15.81% | 16.23% | 18.12% | 11.80% | 12.81% | 10.21% |
Cost of Revenue | 1,268 | 1,215 | 1,030 | 866.05 | 788.1 | 686.93 |
Gross Profit | 327 | 323.16 | 292.79 | 254.14 | 213.88 | 201.23 |
Selling, General & Admin | 228.55 | 227.66 | 210.7 | 184.61 | 156.95 | 142.62 |
Other Operating Expenses | 39.94 | 37.17 | 29.03 | 22.86 | 23.88 | 18.34 |
Operating Expenses | 301.72 | 297.27 | 268.37 | 234.12 | 204.62 | 184.12 |
Operating Income | 25.28 | 25.89 | 24.42 | 20.02 | 9.26 | 17.11 |
Interest Expense | -5.17 | -4.94 | -5.86 | -5.56 | -3.44 | -3.21 |
Interest & Investment Income | 0.29 | 0.11 | 0.08 | 0.08 | 0.03 | 0.24 |
Currency Exchange Gain (Loss) | -2.23 | -3.87 | -0.33 | -2.08 | -0.25 | -2.43 |
Other Non Operating Income (Expenses) | 0.02 | 0.1 | 0.43 | 0.46 | 0.75 | 0.27 |
EBT Excluding Unusual Items | 18.19 | 17.29 | 18.73 | 12.91 | 6.35 | 11.99 |
Gain (Loss) on Sale of Assets | 0.42 | 0.14 | 0.93 | 0.18 | 2.81 | 0.95 |
Asset Writedown | 2.83 | 4.74 | 1.89 | 0.6 | 1.16 | 0.6 |
Pretax Income | 21.43 | 22.17 | 21.55 | 13.69 | 10.32 | 13.53 |
Income Tax Expense | 14.22 | 15.33 | 16.17 | 2.01 | 2.82 | 1.96 |
Earnings From Continuing Operations | 7.21 | 6.85 | 5.38 | 11.68 | 7.49 | 11.57 |
Minority Interest in Earnings | -3.26 | -4.67 | -7.1 | -3.96 | 1.72 | -0.84 |
Net Income | 3.95 | 2.18 | -1.73 | 7.72 | 9.22 | 10.73 |
Net Income to Common | 3.95 | 2.18 | -1.73 | 7.72 | 9.22 | 10.73 |
Net Income Growth | - | - | - | -16.25% | -14.10% | 58.86% |
Shares Outstanding (Basic) | 529 | 511 | 511 | 511 | 511 | 511 |
Shares Outstanding (Diluted) | 529 | 511 | 511 | 511 | 511 | 511 |
Shares Change (YoY) | 3.52% | - | - | - | - | 0.30% |
EPS (Basic) | 0.01 | 0.00 | -0.00 | 0.02 | 0.02 | 0.02 |
EPS (Diluted) | 0.01 | 0.00 | -0.00 | 0.02 | 0.02 | 0.02 |
EPS Growth | - | - | - | -16.25% | -14.11% | 58.38% |
Free Cash Flow | 30.16 | 57.4 | 32.29 | 26.9 | 19.5 | 21.53 |
Free Cash Flow Per Share | 0.06 | 0.11 | 0.06 | 0.05 | 0.04 | 0.04 |
Gross Margin | 20.51% | 21.01% | 22.13% | 22.69% | 21.35% | 22.66% |
Operating Margin | 1.59% | 1.68% | 1.85% | 1.79% | 0.92% | 1.93% |
Profit Margin | 0.25% | 0.14% | -0.13% | 0.69% | 0.92% | 1.21% |
Free Cash Flow Margin | 1.89% | 3.73% | 2.44% | 2.40% | 1.95% | 2.42% |
EBITDA | 43.84 | 44.38 | 41.19 | 36.2 | 24.18 | 31.36 |
EBITDA Margin | 2.75% | 2.89% | 3.11% | 3.23% | 2.41% | 3.53% |
D&A For EBITDA | 18.56 | 18.49 | 16.77 | 16.18 | 14.92 | 14.25 |
EBIT | 25.28 | 25.89 | 24.42 | 20.02 | 9.26 | 17.11 |
EBIT Margin | 1.58% | 1.68% | 1.85% | 1.79% | 0.92% | 1.93% |
Effective Tax Rate | 66.35% | 69.12% | 75.04% | 14.69% | 27.38% | 14.48% |
Revenue as Reported | 1,967 | 1,544 | 1,327 | 1,122 | 1,005 | 890.27 |